Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials

A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients

(2018) Stanley C. Jordan et al.   AMERICAN JOURNAL OF TRANSPLANTATION

A prospective randomized, controlled trial of eculizumab to prevent ischemia-reperfusion injury in pediatric kidney transplantation

(2018) Michael Kaabak et al.   PEDIATRIC TRANSPLANTATION

Donor Urinary C5a Levels Independently Correlate With Posttransplant Delayed Graft Function

(2018) Bernd Schröppel et al.   TRANSPLANTATION

Delayed Graft Function Phenotypes and 12-Month Kidney Transplant Outcomes

(2017) Isaac E. Hall et al.   TRANSPLANTATION

Inhibition of complement improves graft outcome in a pig model of kidney autotransplantation

(2016) Pierre-Olivier Delpech et al.   Journal of Translational Medicine

The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function

(2016) Jagbir Gill et al.   KIDNEY INTERNATIONAL

Potential Roles for C1 Inhibitor in Transplantation

(2016) Mel Berger et al.   TRANSPLANTATION

Complement as a multifaceted modulator of kidney transplant injury

(2014) Paolo Cravedi et al.   JOURNAL OF CLINICAL INVESTIGATION

Delayed kidney graft function: from mechanism to translation

(2014) Bernd Schröppel et al.   KIDNEY INTERNATIONAL

Complement Mediated Renal Inflammation Induced by Donor Brain Death: Role of Renal C5a-C5aR Interaction

(2013) M. B. van Werkhoven et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Acute But Transient Release of Terminal Complement Complex After Reperfusion in Clinical Kidney Transplantation

(2013) Dorottya K. de Vries et al.   TRANSPLANTATION

C3a and C5a Promote Renal Ischemia-Reperfusion Injury

(2012) Q. Peng et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Crosstalk between Complement and Toll-like Receptor Activation in Relation to Donor Brain Death and Renal Ischemia-Reperfusion Injury

(2011) Jeffrey Damman et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Targeting complement activation in brain-dead donors improves renal function after transplantation

(2011) Jeffrey Damman et al.   TRANSPLANT IMMUNOLOGY

Systemic Complement Activation in Deceased Donors Is Associated With Acute Rejection After Renal Transplantation in the Recipient

(2011) Jeffrey Damman et al.   TRANSPLANTATION

YSPSL (rPSGL-Ig) for improvement of early renal allograft function: a double-blind, placebo-controlled, multi-center Phase IIa study1,2,3

(2010) A. Osama Gaber et al.   CLINICAL TRANSPLANTATION

Delayed Graft Function and the Risk for Death with a Functioning Graft

(2009) S. N. Tapiawala et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation

(2009) B. Kruger et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA